OUR HISTORY
Feb 2019
Founded by seasoned pharmaceutical professional, Kunchala Srinivas
Aug 2019
Experienced pharmaceutical professional Dr. Srihari Raju Kalidindi joins Vasavi pharma as Co-Founder
Sep 2019
Acquired controlling stake in Vindhya Pharma, focused on bulk intermediates and APIs
Jul 2020
Commissioned API R&D facility to initiate Vasavi pharma development program across multiple therapeutic categories
Nov 2019
Acquired controlling stake in Vandana Life Sciences, focused on bulk intermediates and APIs
Jul 2020
Commissioned API R&D facility to initiate Vasavi pharma development program across multiple therapeutic categories
Jul 2020
Commissioned API R&D facility to initiate Vasavi pharma development program across multiple therapeutic categories
Jan 2021
Acquired Mylan’s API and Formulations unit in Vizag
May 2021
Acquired Mylan’s US FDA approved API unit in Mumbai
Jun 2021
Acquired 100% ownership in Vindhya Pharma and Vandana Life Sciences
Jun 2021
Investment by Carlyle, one of the largest global PE fund
Jul 2021
Acquired Symed Labs, leading manufacturer of niche APIs
Nov 2021
Acquired majority stake in Appco Pharma LLC, US based generic formulations company
Nov 2021
Acquired 100% stake in Appcure Labs Private Limited, Hyderabad based generic drug development company
WHO WE ARE
Vasavi pharma, true to its name, literally represents honesty and leadership in every sense.
We are an integrated pharmaceutical company with a strong portfolio of niche formulations, APIs and advanced intermediates Vasavi pharma and its subsidiaries operate 10 API / Intermediate facilities with a combined capacity ~2000 KL and diversified capabilities in every aspect – small / large volume, potent / non-potent, regulated / semi-regulated markets.
In addition, we also operate one formulation manufacturing facility in New Jersey, USA with a capacity of ~ 1.2 Bn units.
Leading from the front and staying honest about our origin mission, the two qualities associated with the Vedic interpretation of “Vasavi pharma”, are the propellers of success for any pharmaceutical initiative.We work professionally every day with a single-minded intent to build trust and honest relationships with our community and with our customers.
Our robust API and Formulations R&D infrastructure with a combined strength of over 200 scientists offers expertise across several technologies and complex reactions. Top that with a diversified mix of portfolio across multiple therapy areas such as ARV, CV, CNS, Analgesics, Antibiotics, Antihistamines, Diabetes, GI, Anticoagulants, Oncology etc., and you get the perfect Vasavi pharma potion.
Being young and agile while being bolstered by the heritage and the plethora of experiences the Vasavi pharma family brings with it, sets us well above the industry benchmarks. What we lack in age, we more than make up with our commitment towards our mission; High Quality and Cost efficiency